Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Duval

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Infectious Diseases Now|June 23, 2020
Evaluation of a web-based self-reporting method for monitoring international passengers returning from an area of emerging infectionB Lefèvre, T Blanchon, P Saint-Martin, et al.
Journal of Medical Ethics|September 2, 2008
Informed consent in clinical research in France: assessment and factors associated with therapeutic misconceptionI S Durand-Zaleski, C Alberti, P Durieux, et al.
AJNR. American Journal of Neuroradiology|May 4, 2013
Brain MRI findings in neurologically asymptomatic patients with infective endocarditisA Hess, I Klein, B Iung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2001
Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patientsN Fidouh-Houhou, X Duval, F Bissuel, et al.
Clinical Pharmacology and Therapeutics|October 4, 2012
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patientsR M Savic, A Barrail-Tran, X Duval, et al.
International Journal of Cardiology|July 23, 2019
Antibiotic prophylaxis of infective endocarditis in patients with predisposing cardiac conditions: French cardiologists' implementation of current guidelinesA Cloitre, P Lesclous, Q Trochu, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristicsN Bourgeois-Nicolaos, T T Nguyen, G Defrance, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2018
Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemiaS Siméon, V Le Moing, S Tubiana, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenariansE Comets, B Diquet, S Legrain, et al.
The Journal of Antimicrobial Chemotherapy|May 18, 2020
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make itV de Lastours, C Laouénan, G Royer, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Infectious Diseases Now|June 23, 2020
Evaluation of a web-based self-reporting method for monitoring international passengers returning from an area of emerging infectionB Lefèvre, T Blanchon, P Saint-Martin, et al.
Journal of Medical Ethics|September 2, 2008
Informed consent in clinical research in France: assessment and factors associated with therapeutic misconceptionI S Durand-Zaleski, C Alberti, P Durieux, et al.
AJNR. American Journal of Neuroradiology|May 4, 2013
Brain MRI findings in neurologically asymptomatic patients with infective endocarditisA Hess, I Klein, B Iung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2001
Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patientsN Fidouh-Houhou, X Duval, F Bissuel, et al.
Clinical Pharmacology and Therapeutics|October 4, 2012
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patientsR M Savic, A Barrail-Tran, X Duval, et al.
International Journal of Cardiology|July 23, 2019
Antibiotic prophylaxis of infective endocarditis in patients with predisposing cardiac conditions: French cardiologists' implementation of current guidelinesA Cloitre, P Lesclous, Q Trochu, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristicsN Bourgeois-Nicolaos, T T Nguyen, G Defrance, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2018
Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemiaS Siméon, V Le Moing, S Tubiana, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenariansE Comets, B Diquet, S Legrain, et al.
The Journal of Antimicrobial Chemotherapy|May 18, 2020
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make itV de Lastours, C Laouénan, G Royer, et al.
Pageof 6